


With so much capital in the market, deal pricing has become inflated, with sellers holding out for better bids. GPs, however, appear to be balking at the overvaluations, according to recent data showing PE-backed deal activity is slowing. Once the cycle turns and prices fall, GPs will be well-stocked with capital to chase opportunities.